Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-epitope vaccine against drug-resistant strains of Mycobacterium tuberculosis: a proteome-wide subtraction and immunoinformatics approach

27 Sept 2023

Abstract excerpt

Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, one of the most deadly infections in humans. The emergence of multidrug-resistant and extensively drug-resistant Mtb strains presents a global challenge. Mtb has shown resistance to many frontline antibiotics, including rifampicin, kanamycin, isoniazid, and capreomycin. The only licensed vaccine, Bacille Calmette-Guerin, does not efficiently...

Topics

Join the communities discussing this publication.

RNA and protein synthesis mechanisms
Tuberculosis Research and Epidemiology
vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37813638
DOI: 10.5808/gi.23021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-epitope vaccine against drug-resistant strains of Mycobacterium tuberculosis: a proteome-wide subtraction and immunoinformatics approachPMID 37813638Read ↗

An Immunoinformatic strategy to develop new Mycobacterium tuberculosis multi-epitope vaccineSemantic proximity Read ↗

Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosisSemantic proximity Read ↗

A vaccine for global eradication of TB - A novel conceptual framework and design of a potent peptide-based vaccine with universal coverage through advanced computational vaccinologySemantic proximity Read ↗

Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modificationsSemantic proximity Read ↗

PBITV3 : A robust and comprehensive tool for screening pathogenic proteomes for drug targets and prioritizing vaccine candidatesSemantic proximity Read ↗

Proteome Exploration of Legionella pneumophila To Identify Novel Therapeutics: a Hierarchical Subtractive Genomics and Reverse Vaccinology ApproachSemantic proximity Read ↗

Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approachSemantic proximity Read ↗

New Advances in the Development and Design of Mycobacterium tuberculosis Vaccines: Construction and Validation of Multi-Epitope Vaccines for Tuberculosis PreventionSemantic proximity Read ↗

Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approachesSemantic proximity Read ↗

Whole genome identification of Mycobacterium tuberculosisvaccine candidates by comprehensive data mining and bioinformatic analysesSemantic proximity Read ↗

A mutation-aware proteomics approach for designing a multi-epitope vaccine against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.Semantic proximity Read ↗

Proteome Exploration of <i>Legionella pneumophila</i> for Identifying Novel Therapeutics: A Hierarchical Subtractive Genomics and Reverse Vaccinology ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.